Zealand Pharma A/S (ZLDPF)
41.99
0.00 (0.00%)
USD |
OTCM |
Sep 25, 16:00
Zealand Pharma Net Income (TTM) : 425.33M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 425.33M |
| March 31, 2026 | 966.41M |
| December 31, 2025 | 980.80M |
| September 30, 2025 | 998.26M |
| June 30, 2025 | 1.022B |
| March 31, 2025 | -170.41M |
| December 31, 2024 | -156.38M |
| September 30, 2024 | -152.93M |
| June 30, 2024 | -102.89M |
| March 31, 2024 | -107.31M |
| December 31, 2023 | -101.94M |
| September 30, 2023 | -107.79M |
| June 30, 2023 | -139.17M |
| March 31, 2023 | -149.46M |
| December 31, 2022 | -135.87M |
| September 30, 2022 | -124.23M |
| June 30, 2022 | -126.09M |
| March 31, 2022 | -117.31M |
| December 31, 2021 | -142.20M |
| September 30, 2021 | -170.77M |
| June 30, 2021 | -184.24M |
| March 31, 2021 | -144.65M |
| December 31, 2020 | -131.90M |
| September 30, 2020 | -99.65M |
| June 30, 2020 | -80.63M |
| Date | Value |
|---|---|
| March 31, 2020 | -92.67M |
| December 31, 2019 | -85.60M |
| September 30, 2019 | -75.71M |
| June 30, 2019 | 84.59M |
| March 31, 2019 | 87.58M |
| December 31, 2018 | 90.91M |
| September 30, 2018 | 92.21M |
| June 30, 2018 | -58.02M |
| March 31, 2018 | -54.34M |
| December 31, 2017 | -42.05M |
| September 30, 2017 | -16.90M |
| June 30, 2017 | -14.73M |
| March 31, 2017 | -15.64M |
| December 31, 2016 | -23.36M |
| September 30, 2016 | -20.77M |
| June 30, 2016 | -23.78M |
| March 31, 2016 | -20.30M |
| December 31, 2015 | -17.18M |
| September 30, 2015 | -37.98M |
| June 30, 2015 | -27.34M |
| March 31, 2015 | -24.72M |
| December 31, 2014 | -11.05M |
| September 30, 2014 | -8.648M |
| June 30, 2014 | -17.79M |
| March 31, 2014 | -17.24M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Genmab A/S | 785.93M |
| Ascendis Pharma A/S | 866.59M |
| Bavarian Nordic A/S | 241.04M |
| Evaxion AS | -8.683M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |